Top News

Check back for the latest 2019 press releases.

March 28, 2019

Velicept Therapeutics Announces Positive Top-Line Phase 2b Results for Solabegron in the Treatment of Overactive Bladder (OAB)

Please reload

NeXeption

640 Lee Road, Ste 110

Wayne, PA 19087

T +1 484.318.2988

F +1 484.324.7949

Nexeption Logo